Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.
about
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseRecombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge.Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.Vaccines for Emerging Infectious Diseases: lessons from MERS coronavirus and Zika virus.An update on Middle East respiratory syndrome: 2 years later.Vaccines for the prevention against the threat of MERS-CoV.Middle East respiratory syndrome: current status and future prospects for vaccine development.Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC.An Opportunistic Pathogen Afforded Ample Opportunities: Middle East Respiratory Syndrome Coronavirus.Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.
P2860
Q30378994-137692E1-9E56-42A1-9781-57490EFAF980Q30400066-B0E446CE-7FBA-4802-98B9-F224D9407232Q34468689-094B1FD9-BC11-4D2F-A631-710FBBA3843BQ36252666-8F085514-0EB4-477B-A7DE-3D33CAF710CCQ37169882-E9D41CC8-F614-4DEA-96E9-0FEDFAD98D2DQ37717377-CABDFC4D-3649-4976-8821-CB2DF2D011F8Q38156536-E9BA25C2-A706-43C8-A6F1-59C999482211Q38384184-96D85197-1AAF-4467-89A3-3AA2FB376989Q38778044-299730F6-872C-419E-A4C2-1DB4DE718321Q38959242-4DBECCC3-5955-4703-80B2-2083FC2AD2CCQ38992327-03CED408-2588-485D-9D56-01E9CD01E731Q39102732-A477D4F8-1120-47FA-BDA8-83FCB37533ACQ40428932-F38A6975-EF20-4DAE-8FBD-E869CB7D5C1BQ47132991-F45599D3-4575-4823-892B-8C39E08E402DQ47607374-D8F37831-30EE-4739-B3DB-9E0631847E45Q54241763-751FBBC4-0E0C-4BF2-AC63-7CDD98B8FB1A
P2860
Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tailoring subunit vaccine immu ...... -binding domain as an antigen.
@ast
Tailoring subunit vaccine immu ...... -binding domain as an antigen.
@en
type
label
Tailoring subunit vaccine immu ...... -binding domain as an antigen.
@ast
Tailoring subunit vaccine immu ...... -binding domain as an antigen.
@en
prefLabel
Tailoring subunit vaccine immu ...... -binding domain as an antigen.
@ast
Tailoring subunit vaccine immu ...... -binding domain as an antigen.
@en
P2093
P2860
P1433
P1476
Tailoring subunit vaccine immu ...... -binding domain as an antigen.
@en
P2093
Guangwen Lu
Jiaming Lan
Wenjie Tan
Xiaojuan Guo
P2860
P304
P356
10.1371/JOURNAL.PONE.0112602
P407
P577
2014-11-18T00:00:00Z